
Alpha Pro Tech, Ltd.: stock overview
Price
$6.18
November 13, 2026Market cap $63M
What Ploutos Investor adds for Alpha Pro Tech
Part of Ploutos Investor, €9.99 a month
- The full history: 16 fiscal years, from 2010
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
In short
Alpha Pro Tech had revenue of $64M over the last 12 months and net income of $5.2M, a net margin of 8.1%. Revenue fell by 10.5% a year on average over the last 5 years. At $6.18 the shares trade at a P/E of 12.2, against a median of 15.1 over the last 5 fiscal years. It holds more cash than debt, by $26M. It pays no dividend.
From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.
Its SEC filings- Market cap
- $63M
- 10.19M shares
- P/E
- 12.2
- Today12.2Median15.1
- Revenue, 12 months
- $64M
- -10.5% a year over 5 years
- Net margin
- 8.1%
- 2025: 5.9%, above 62% of its industry
Worth knowing
What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.
3 fiscal years in figures
Each fiscal year's figures as the company filed them, and the share price at its end.
-1.7% a year over 2 years
Fiscal years in figures
APT's revenue, profit, cash flow and dividend with each year-end price, from 2010 to 2022, 13 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Key figures
The company's current figures in five groups. Each term is explained behind its ⓘ.
Valuation
- Market cap 3-year median: $58M
- $63M
- Enterprise value
- $37M
- P/E 3-year median: 15.1
- 12.2
- EV / EBIT
- 6.8
- EV / Revenue
- 0.6
- P/B 3-year median: 0.9
- 1.0
- FCF yield 3-year median: 3.8%
- 14.4%
- Earnings yield 3-year median: 6.6%
- 8.2%
Profitability
- Gross margin
- 38.6%
- Operating margin
- 8.6%
- Net margin 3-year median: 6.8%
- 8.1%
- ROIC
- 6.8%
- ROIC, 5-year average
- 6.1%
- ROE
- 8.1%
Growth
- Revenue, yearly change
- +2.3%
- EPS, yearly change
- -5.7%
- FCF, yearly change
- -8.5%
- Revenue, average a year
- -10.5%
- EPS, average a year
- -29.7%
The yearly change compares FY2025 with FY2024.
Balance sheet
- Cash
- $26M
- Total debt
- $7.4M
- Of which operating leases
- $7.4M
- Net cash
- $26M
- Net debt / EBITDA
- -4.0x
- Interest cover
- –
- Current ratio
- 8.71
Balance sheet of September 30, 2026.
Returns to shareholders
- Dividend yield
- 0.00%
- Buybacks
- 5.31%
- Total returned
- 5.31%
- Shares, yearly change
- -6.3%
Against its industry
Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 38).
Gross margin
38.1%
Above 20% of the 161 companies in its industry, and 53% of all.
Operating margin
6.5%
Above 56% of the 186 companies in its industry, and 55% of all.
Net margin
5.9%
Above 62% of the 189 companies in its industry, and 55% of all.
ROE
5.6%
Above 59% of the 174 companies in its industry, and 45% of all.
ROA
4.7%
Above 67% of the 190 companies in its industry, and 71% of all.
Revenue growth
2.3%
Above 30% of the 186 companies in its industry, and 36% of all.
From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.
The company at the SEC
How it is registered and when its fiscal year ends.
- Name at the SEC
- ALPHA PRO TECH LTD
- CIK
- 884269
- Exchange
- AMEX
- Industry (SIC)
- 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Fiscal year ends
- December 31
- Latest annual report
- December 31, 2025
- Reporting currency
- USD
- Shares
- 10.19M
Other companies: Healthcare
The largest companies of the same sector, each with its own page.
- LLYEli Lilly and Company+0,00%Compare with APT
- JNJJohnson & Johnson+0,00%Compare with APT
- ABBVAbbVie+0,00%Compare with APT
- UNHUnitedHealth+0,00%Compare with APT
- MRKMerck & Company+0,00%Compare with APT
- AMGNAmgen+0,00%Compare with APT
- TMOThermo Fisher Scientific+0,00%Compare with APT
- ABTAbbott Laboratories+0,00%Compare with APT
The full analysis
What do Alpha Pro Tech's filings show?
These are Alpha Pro Tech's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is APT's market cap?
Alpha Pro Tech, Ltd.'s market cap is $63M, at a price of $6.18 on November 13, 2026 and 10.19M shares.
What is APT's P/E?
APT's P/E is 12.2, on earnings per share of $0.50 over the last 12 months. The median over the last 5 fiscal years was 15.1.
How much revenue does APT have?
Alpha Pro Tech had revenue of $64M over the last 12 months. Over the last 5 years it changed by -10.5% a year on average.
Does APT pay a dividend?
No. Alpha Pro Tech paid no regular dividend over the last 12 months.
Where do the figures come from?
From Alpha Pro Tech, Ltd.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.